News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,363 Results
Type
Article (413)
Company Profile (2)
Press Release (3948)
Section
Business (1589)
Career Advice (8)
Deals (244)
Drug Delivery (4)
Drug Development (812)
FDA (137)
Job Trends (190)
News (2767)
Policy (268)
Tag
Academia (14)
Alliances (458)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (5)
Approvals (138)
Artificial intelligence (1)
Bankruptcy (3)
Best Places to Work (164)
Biotechnology (2)
Bladder cancer (3)
Breast cancer (1)
Cancer (26)
Career advice (7)
Career pathing (4)
CAR-T (4)
Cell therapy (15)
Clinical research (717)
Collaboration (13)
COVID-19 (5)
CRISPR (1)
C-suite (3)
Cystic fibrosis (1)
Data (13)
Diagnostics (5)
Drug discovery (4)
Drug pricing (6)
Earnings (511)
Events (613)
Executive appointments (7)
FDA (145)
Funding (8)
Gene editing (3)
Gene therapy (10)
GLP-1 (6)
Government (32)
Healthcare (33)
Infectious disease (5)
Inflation Reduction Act (3)
Intellectual property (2)
IPO (92)
IRA (4)
Job creations (29)
Job search strategy (3)
Labor market (3)
Layoffs (14)
Leadership (1)
Legal (41)
Lung cancer (2)
Manufacturing (2)
Medical device (2)
Medtech (2)
Mergers & acquisitions (155)
Metabolic disorders (1)
Neuroscience (1)
NextGen: Class of 2025 (29)
Non-profit (27)
Northern California (33)
Opinion (4)
Pancreatic cancer (1)
Partnered (1)
People (559)
Phase I (185)
Phase II (261)
Phase III (344)
Pipeline (16)
Policy (6)
Postmarket research (18)
Preclinical (48)
Prostate cancer (4)
Radiopharmaceuticals (2)
Rare diseases (1)
Real estate (21)
Regulatory (220)
Reports (1)
Research institute (3)
Series A (1)
Southern California (22)
Special edition (1)
Spinal muscular atrophy (7)
Startups (42)
Stomach cancer (2)
The Weekly (2)
United States (131)
Vaccines (2)
Venture capitalists (2)
Weight loss (1)
Women's health (3)
Date
Last 7 days (3)
Last 30 days (12)
Last 365 days (223)
2025 (49)
2024 (254)
2023 (353)
2022 (409)
2021 (395)
2020 (404)
2019 (288)
2018 (219)
2017 (212)
2016 (254)
2015 (222)
2014 (165)
2013 (149)
2012 (168)
2011 (202)
2010 (180)
Location
Africa (2)
Arizona (1)
Asia (596)
Australia (14)
California (60)
Canada (5)
China (4)
Europe (442)
Georgia (3)
Illinois (13)
Indiana (2)
Japan (20)
Maryland (2)
Massachusetts (27)
Michigan (1)
New Jersey (6)
New York (6)
Northern California (33)
Ohio (1)
Pennsylvania (5)
South America (5)
Southern California (22)
Texas (1)
Washington D.C. (2)
Washington State (6)
4,363 Results for "astellas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chromatin Bioscience Signs Collaboration Agreement with Astellas
April 14, 2025
·
2 min read
Press Releases
Astellas Makes Announcement about Management Structure
February 4, 2025
·
5 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing
March 6, 2025
·
4 min read
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting
March 24, 2025
·
1 min read
Layoffs
Astellas Gene Therapies to Close Biomanufacturing Facility, Affecting About 100 Employees
Astellas Gene Therapies is closing its San Francisco biomanufacturing facility, shifting gene therapy manufacturing to North Carolina, cutting at least 17 employees and affecting dozens more.
September 3, 2024
·
1 min read
·
Angela Gabriel
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
FDA
Astellas’ Hot Flash Drug Veozah Slapped With Another FDA Warning for Liver Injury
One patient developed elevated liver blood tests after receiving Astellas Pharma’s non-hormonal small molecule blocker, leading the regulator to add a warning to the drug’s label.
September 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan
February 5, 2025
·
6 min read
1 of 437
Next
